Gilead Sciences
GILD
#129
Rank
HK$1.170 T
Marketcap
HK$943.65
Share price
-1.14%
Change (1 day)
34.64%
Change (1 year)

Gilead Sciences (GILD) - Total debt

Total debt on the balance sheet as of September 2025 : HK$194.15 Billion

According to Gilead Sciences's latest financial reports the company's total debt is HK$194.15 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Gilead Sciences - Total debt on balance sheet (from 1996 to 2025)

Total debt by year

Year Total debt Change
2024-12-31HK$207.37 B6.26%
2023-12-31HK$195.14 B-1%
2022-12-31HK$197.12 B-5.3%
2021-12-31HK$208.15 B-14.49%
2020-12-31HK$243.43 B27.1%
2019-12-31HK$191.53 B-10.48%
2018-12-31HK$213.95 B-18.36%
2017-12-31HK$262.06 B28.27%
2016-12-31HK$204.30 B19.52%
2015-12-31HK$170.94 B77.67%
2014-12-31HK$96.21 B86.97%
2013-12-31HK$51.45 B-19.28%
2012-12-31HK$63.74 B7.89%
2011-12-31HK$59.08 B117.86%
2010-12-31HK$27.12 B180.17%
2009-12-31HK$9.67 B7.96%
2008-12-31HK$8.96 B-12.35%
2007-12-31HK$10.22 B-6.76%
2006-12-31HK$10.97 B370.32%
2005-12-31HK$2.33 B72228.44%
2004-12-31HK$3.22 M-99.88%
2003-12-31HK$2.67 B-42.34%
2002-12-31HK$4.64 B136.44%
2001-12-31HK$1.96 B-1.35%
2000-12-31HK$1.99 B191.3%
1999-12-31HK$0.68 B-13.09%
1998-12-31HK$0.78 B3071.1%
1997-12-31HK$24.79 M-50.68%
1996-12-31HK$50.27 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Amgen
AMGN
HK$424.93 B 118.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
HK$14.28 B-92.64%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
HK$535.13 B 175.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
HK$20.05 B-89.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
HK$51.30 B-73.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$473.67 B 143.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$356.49 B 83.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$330.89 B 70.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$322.08 B 65.89%๐Ÿ‡บ๐Ÿ‡ธ USA